In PDA cells, GEM treatment increased HK2-VDAC1 binding through ROS production, and the consequent antiapoptotic effect could be related to GEM resistance; in fact, overexpression of HK2 in PDA patients correlated with GEM resistance [29]. The gene discussed is HK2; the disease is Patent ductus arteriosus.